Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease

University of North Carolina, Chapel Hill · with National Heart, Lung, and Blood Institute (NHLBI) · NCT00807482

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Any age listed · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
1800
US sites recruiting
1
Study start
January 2004
Record last updated
June 29, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The overall short-term goals of this project include the following: 1) identify the genes that are key to the function of respiratory cilia to protect the normal lung; and 2) the effects of genetic mutations that adversely affect ciliary function and cause primary ciliary dyskinesia (PCD), which results in life-shortening lung disease. The long-term goal of this project is to develop better understanding of the underlying genetic variability that adversely modifies ciliary function, and predisposes to common airway diseases, such as asthma and chronic obstructive pulmonary disease.

Conditions: Kartagener Syndrome

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Patients who have a high suspicion for the diagnosis of PCD, based on clinical features

Healthy Volunteers who have a family member with confirmed PCD.

Recruiting US locations

  • The University of North Carolina at Chapel Hill

    Chapel Hill, NC 27599

    Site contact: Kelli Sullivan · 919-962-9786 · kelli_sullivan@med.unc.edu

Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease (NCT00807482) | Bored Studies